Abstract
Ammonia is thought to play a significant role in the development of hepatic encephalopathy (HE) in patients with liver failure. Some of the key questions have been whether there is an abnormal permeability surface-area product across the blood-brain barrier (PSBBB) for ammonia in patients with cirrhosis and whether the cerebral metabolic rate of ammonia is altered. In this chapter, we discuss how functional molecular imaging using positron emission tomography (PET) can be utilized for in vivo studies of cerebral ammonia kinetics and what the studies so far have shown.
Keywords: Hepatic encephalopathy; Blood-brain barrier; Permeability surface-area product.
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents